Analysis Tools
mortality/aging
|
• most S. aureus-infected mice die unlike similarly treated wild-type mice
|
immune system
|
• in S.aureus-infected mice
|
|
• in S.aureus-infected mice
|
|
• in S.aureus-infected mice
|
|
• in S.aureus-infected mice
|
|
• in S.aureus-infected mice
|
|
• 28 days after S. aureus infection
|
|
• from spleen cells of S. aureus-infected mice
|
|
• S. aureus-infected mice exhibit decreased septic arthritis compared with similarly treated wild-type mice
|
|
• Staphylococcus aureus-infected mice exhibit greater weight loss, increased mortality, reduced bacterial clearance, decreased IFN-gamma production, decreased septic arthritis, increased IgM serum levels, and decreased antigen-specific IgG serum levels compared with similarly treated wild-type mice
|
|
• most S. aureus-infected mice die unlike similarly treated wild-type mice
|
skeleton
|
• S. aureus-infected mice exhibit decreased septic arthritis compared with similarly treated wild-type mice
|
homeostasis/metabolism
|
• 28 days after S. aureus infection
|
behavior/neurological
|
• mice exhibit reduced rapid eye movement (REM) sleep episode frequency compared with wild-type mice
• mice exhibit higher absolute electroencephalogram (EEG) power density non-REM sleep within the slow-wave range compared with wild-type mice
• after sleep deprivation, mice exhibit a greater increase in fast 'slow waves' compared with wild-type mice
• however, a decrease in non-REM sleep episode frequency is compensated by extension of non-REM sleep episode duration
|
hematopoietic system
|
• in S.aureus-infected mice
|
|
• in S.aureus-infected mice
|
|
• in S.aureus-infected mice
|
|
• in S.aureus-infected mice
|
|
• in S.aureus-infected mice
|
cellular
|
• in S.aureus-infected mice
|
